Eli Lilly and Company
NYSE:LLY · New York Stock Exchange
-$10.54 today
Vol 2.77M · Avg 3.19M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+43.51%
Period High
$1,160.95
Period Low
$621.25
Latest
$1,098.13
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector

Johnson & Johnson
NYSE:JNJ
$552.89B

AbbVie Inc.
NYSE:ABBV
$382.93B

Merck & Co., Inc.
NYSE:MRK
$282.33B

Novartis AG
NYSE:NVS
$281.96B

AstraZeneca PLC
NYSE:AZN
$271.39B

Novo Nordisk A/S
NYSE:NVO
$191.48B

Amgen Inc.
NASDAQ:AMGN
$180.94B

Gilead Sciences, Inc.
NASDAQ:GILD
$152.75B

Pfizer Inc.
NYSE:PFE
$144.02B

Sanofi
NASDAQ:SNY
$101.57B
What is the latest LLY filing?
The latest filing shown is 4 dated Jun 16, 2026.
How many recent filings does LLY have?
Intrinsic Alpha currently shows 20 recent filings for LLY.
Explore More
Continue the stock analysis
Jump to another research area for this company.